HomeNKTR • NASDAQ
Follow
Nektar Therapeutics
Previous close
$1.67
Day range
$1.50 - $1.70
Year range
$0.41 - $1.75
Market cap
288.28M USD
Avg Volume
3.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 23.88M | 8.45% |
Operating expense | 47.26M | -16.61% |
Net income | -42.08M | 29.50% |
Net profit margin | -176.17 | 35.00% |
Earnings per share | -0.22 | 31.25% |
EBITDA | -29.01M | 23.07% |
Effective tax rate | 0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 303.62M | -39.88% |
Total assets | 398.03M | -43.99% |
Total liabilities | 267.05M | -22.36% |
Total equity | 130.99M | — |
Shares outstanding | 183.62M | — |
Price to book | 2.46 | — |
Return on assets | -18.24% | — |
Return on capital | -20.02% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -42.08M | 29.50% |
Cash from operations | -47.05M | 18.47% |
Cash from investing | 17.38M | -56.56% |
Cash from financing | 12.00K | -88.35% |
Net change in cash | -29.64M | -69.09% |
Free cash flow | -16.51M | 10.69% |
About
Founded
1990
Headquarters
Website
Employees
137
